|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 August 2000, Vol. 96, No. 4, pp. 1490-1495
IMMUNOBIOLOGY
Histone deacetylase inhibitors suppress IL-2-mediated
gene expression prior to induction of apoptosis
Yuko Koyama,
Masaaki Adachi,
Masuo Sekiya,
Mutsuhiro Takekawa, and
Kohzoh Imai
From the First Department of Internal Medicine,
Sapporo Medical University School of Medicine, Sapporo,
Japan.
Histone deacetylase (HDAC) inhibitors can induce transcriptional
activation of a number of genes and induce cellular differentiation as
histone acetylation levels increase. Although these inhibitors induce
apoptosis in several cell lines, the precise mechanism by which they do
so remains obscure. This study shows that HDAC inhibitors, sodium
butyrate and trichostatin A (TSA), abrogate interleukin
(IL)-2-mediated gene expression in IL-2-dependent cells. The HDAC
inhibitors readily induced apoptosis in IL-2-dependent ILT-Mat cells
and BAF-B03 transfectants expressing the IL-2 receptor  c chain,
whereas they induced far less apoptosis in cytokine-independent K562
cells. However, these inhibitors similarly increased acetylation levels
of histones in both cells. Although histone hyperacetylation is
believed to lead to transcriptional activation, the results showed an
abrogation of IL-2-mediated induction of c-myc,
bag-1, and LC-PTP gene expression. This
observed abrogation of gene expression occurred prior to
phosphatidylserine externalization, a process that occurs in early
apoptotic cells. Considering the biologic role played by
IL-2-mediated gene expression in cell survival, these data suggest
that its abrogation may contribute to the apoptotic process induced by
HDAC inhibitors.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
W. Cao, C. Bao, E. Padalko, and C. J. Lowenstein
Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling
J. Exp. Med.,
June 9, 2008;
205(6):
1491 - 1503.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Piekarz, R. W. Robey, Z. Zhan, G. Kayastha, A. Sayah, A. H. Abdeldaim, S. Torrico, and S. E. Bates
T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance
Blood,
June 15, 2004;
103(12):
4636 - 4643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Mori, T. Matsuda, M. Tadano, T. Kinjo, Y. Yamada, K. Tsukasaki, S. Ikeda, Y. Yamasaki, Y. Tanaka, T. Ohta, et al.
Apoptosis Induced by the Histone Deacetylase Inhibitor FR901228 in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells
J. Virol.,
May 1, 2004;
78(9):
4582 - 4590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Nusinzon and C. M. Horvath
Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1
PNAS,
December 9, 2003;
100(25):
14742 - 14747.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-W. Cheong, S. Y. Chong, J. Y. Kim, J. I. Eom, H. K. Jeung, H. Y. Maeng, S. T. Lee, and Y. H. Min
Induction of Apoptosis by Apicidin, a Histone Deacetylase Inhibitor, via the Activation of Mitochondria-Dependent Caspase Cascades in Human Bcr-Abl-Positive Leukemia Cells
Clin. Cancer Res.,
October 15, 2003;
9(13):
5018 - 5027.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Kang, Y. Zhang, J. Chen, H. Chen, C. Lin, Q. Wang, and Y. Ou
Nickel-Induced Histone Hypoacetylation: The Role of Reactive Oxygen Species
Toxicol. Sci.,
August 1, 2003;
74(2):
279 - 286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Aron, M. R. Parthun, G. Marcucci, S. Kitada, A. P. Mone, M. E. Davis, T. Shen, T. Murphy, J. Wickham, C. Kanakry, et al.
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein
Blood,
July 15, 2003;
102(2):
652 - 658.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rascle, J. A. Johnston, and B. Amati
Deacetylase Activity Is Required for Recruitment of the Basal Transcription Machinery and Transactivation by STAT5
Mol. Cell. Biol.,
June 15, 2003;
23(12):
4162 - 4173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Yu, M. Rahmani, J. Almenara, M. Subler, G. Krystal, D. Conrad, L. Varticovski, P. Dent, and S. Grant
Histone Deacetylase Inhibitors Promote STI571-mediated Apoptosis in STI571-sensitive and -resistant Bcr/Abl+ Human Myeloid Leukemia Cells
Cancer Res.,
May 1, 2003;
63(9):
2118 - 2126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Skov, K. Rieneck, L. F. Bovin, K. Skak, S. Tomra, B. K. Michelsen, and N. Odum
Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression
Blood,
February 15, 2003;
101(4):
1430 - 1438.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Weston, R. A.S. Chandraratna, J. Torchia, and T. M. Underhill
Requirement for RAR-mediated gene repression in skeletal progenitor differentiation
J. Cell Biol.,
July 8, 2002;
158(1):
39 - 51.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Piekarz, R. Robey, V. Sandor, S. Bakke, W. H. Wilson, L. Dahmoush, D. M. Kingma, M. L. Turner, R. Altemus, and S. E. Bates
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report
Blood,
November 1, 2001;
98(9):
2865 - 2868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-G. Zhu, R. R. Lakshmanan, M. D. Beal, and G. A. Otterson
DNA Methyltransferase Inhibition Enhances Apoptosis Induced by Histone Deacetylase Inhibitors
Cancer Res.,
February 1, 2001;
61(4):
1327 - 1333.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. M. Mehl, J. E. Floettmann, M. Jones, P. Brennan, and M. Rowe
Characterization of Intercellular Adhesion Molecule-1 Regulation by Epstein-Barr Virus-encoded Latent Membrane Protein-1 Identifies Pathways That Cooperate with Nuclear Factor kappa B to Activate Transcription
J. Biol. Chem.,
January 5, 2001;
276(2):
984 - 992.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Leoni, A. Zaliani, G. Bertolini, G. Porro, P. Pagani, P. Pozzi, G. Dona, G. Fossati, S. Sozzani, T. Azam, et al.
The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines
PNAS,
March 5, 2002;
99(5):
2995 - 3000.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
